Skip to main content
Gem Aromatics Limited logo

Gem Aromatics Limited — Investor Relations & Filings

Ticker · GEMAROMA ISIN · INE06XZ01023 LEI · 335800ZZAE23XEGGOB31 BSE.NS Manufacturing
Open in API
Filings indexed 118 across all filing types
Latest filing 2026-05-21 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS GEMAROMA

About Gem Aromatics Limited

https://gemaromatics.com/

Gem Aromatics Limited is a manufacturer and exporter specializing in aroma chemicals, essential oils, and menthol-based products. The company’s core portfolio includes menthol crystals, peppermint oil, spearmint oil, and various natural essential oils. These products serve as critical ingredients for the pharmaceutical, food and beverage, cosmetic, and fragrance sectors. The organization maintains a focus on quality assurance through standardized processing and distillation techniques, ensuring compliance with international safety and purity requirements. Its operations are geared toward providing consistent aromatic compounds and natural extracts to a global client base, supporting diverse industrial formulations.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 78% confidence The document is a SEBI‐mandated outcome of a board meeting filing to BSE/NSE disclosing the approved Unaudited Quarterly Results for Q4 March 31, 2026 and the Audited Year End Results for FY 2025-26, complete with the Auditor’s Report and full financial statements. It is not a full annual report (10-K) or merely a press release of highlights; it includes substantive financial data and auditor opinions, fitting the definition of an Interim/Quarterly Report under our taxonomy. FY 2026
2026-05-21 English
Outcome of Board Meeting of Gem Aromatics Limited conducted on May 21, 2026
Interim / Quarterly Report Classification · 95% confidence The document is a formal Board Meeting outcome filed under SEBI Listing Regulations 30 and 33, including the unaudited financial results for the quarter ended March 31, 2026 and the audited consolidated financial results for the year ended March 31, 2026. It contains actual financial statements (P&L summary, assets & liabilities, cash flows) and the auditor’s report. This is more than a brief earnings release and not a full annual report. It fits the definition of an Interim/Quarterly Report containing substantive financial data. FY 2026
2026-05-21 English
Intimation of Conference call with Investors and Analysts.
Regulatory Filings Classification · 85% confidence The document is an official notice under SEBI LODR Regulation 30 to stock exchanges announcing the date, time and dial-in details for the company’s Q4 & FY26 investors/analysts conference call. It contains no substantive financial data or actual earnings content, no presentation slides, and no transcript. It is a regulatory announcement rather than a report itself or a transcript, fitting the fallback category for general regulatory filings.
2026-05-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is an intimation under SEBI (LODR) Regulation 30 informing exchanges of an upcoming investors and analysts conference call to discuss audited financial results. It contains dial-in details and call logistics, not the actual earnings release, financial statements, or call transcript itself. This type of event/ compliance announcement falls under general regulatory filings (fallback category).
2026-05-18 English
Board Meeting — Board Meeting Intimation
Regulatory Filings Classification · 74% confidence The document is an XBRL instance notifying a board meeting (“TypeOfMeeting: Board Meeting”) to consider audited financial results for the quarter and year ended March 31, 2026. It is a statutory intimation of a meeting rather than the report itself, so it falls under general regulatory announcements. It does not announce any board changes (MANG), nor is it the actual earnings release (ER) or report. Therefore, it is best classified as a Regulatory Filing (RNS).
2026-05-18 English
Board Meeting — Financial Results
Regulatory Filings Classification · 75% confidence The document is a notice to stock exchanges under SEBI Listing Regulations about the scheduled Board meeting to consider and approve audited financial results and the trading window closure. It does not contain actual financial results or report text itself, nor is it announcing the publication of a report. It is a regulatory/intimation filing under Listing Obligations. There are no changes in management, no proxy materials, no dividend notice, no share actions. Therefore, it falls under general regulatory announcements (Regulatory Filings).
2026-05-18 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.